Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3 Recurrence 2 Pancreatic Neoplasms 2 Lymphoma, B-Cell 2 Liver Neoplasms 2 Hematologic Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Metastatic Solid Tumors 1 Mesothelioma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Hemorrhage 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Gynecological Solid Tumors 1 Fallopian Tube Neoplasms 1 Erectile Dysfunction 1 Diarrhea 1 Colitis 1 Childhood Solid Tumor 1 Carcinoma, Hepatocellular 1

Interventions

Tranexamic Acid 13 Sodium Chloride 4 Misoprostol 4 Saline Solution 3 Enoxaparin 3 carbetocin 2 Tourniquets 2 Ringer's Lactate 2 Oxytocin 2 Endoscopic Mucosal Resection 2 Dalteparin 2 Aspirin 2 maleimide-polyethylene glycol-modified hemoglobin, MP4 1 bemiparin 1 Vitamin B 6 1 Vasopressins 1 Uterine Myomectomy 1 Uterine Artery Embolization 1 Ultrasonography 1 Tinzaparin 1 Thoracic Surgery, Video-Assisted 1 Terlipressin 1 Sutures 1 Surveys and Questionnaires 1 Surgicel 1 Standard of Care 1 Solutions 1 Sensitivity Training Groups 1 Rivaroxaban 1 Ringer's Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hemorrhage × Cell- and Tissue-Based Therapy × Clear all

NCT02814864 2021-08-03

PRISME

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Colitis, Diarrhea, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡